Flow cytometry was performed on a pooled tear fluid sample. Aliquots of 20 μL
Dynabeads® (Exosome-Human CD9 Flow Detection Reagent, Invitrogen, Thermo Fisher Scientific, Oslo, Norway, Cat no 10620D) were added to 100 μL of the tear fluid sample and to each of three controls (negative control: assay buffer; positive control: SW−480 cell line EVs; ISO-control: tear fluid). Overnight incubation was performed in a HulaMixer Sample Mixer at 2–8 °C. Following wash steps, 150 μL of assay buffer was used to redistribute the beads, and 100 μL from each sample was then combined with 25 μL of PE-conjugated detection antibodies (
CD9-PE, Cat no 555372, BD Biosciences, Oslo, Norway) or 25 μL of isotype-matched control (
IgG1-PE, Cat no 559320, BD Biosciences, Oslo, Norway). An orbital shaker (IKA-WERKE GMBH & CO, Staufen, Germany) was then used for 45 min at 1000 rpm. Following two wash steps, a final 100 μL of assay buffer was added to each tube. All samples and controls were then placed on ice, ready for flow cytometry analysis. A
BD Accuri™ C6 Cytometer (BD Biosciences, Oslo, Norway) was used for flow cytometry EV detection.
Cross T., Øvstebø R., Brusletto B.S., Trøseid A.M., Olstad O.K., Aspelin T., Jackson C.J., Chen X., Utheim T.P, & Haug K.B. (2023). RNA Profiles of Tear Fluid Extracellular Vesicles in Patients with Dry Eye-Related Symptoms. International Journal of Molecular Sciences, 24(20), 15390.